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Abstract
Background: The prevalence of diabetes mellitus (DM) is increasing dramatically, placing considerable financial
burden on the healthcare budget of each country. Patient self-management is crucial for the control of blood
glucose, which largely determines the chances of developing diabetes-related complications. Self-management
interventions vary widely, and a method is required for assessing the impact of self-management. This paper
describes the development of a questionnaire intended for use to measure the impact of self-management in
diabetes.
Methods: An iterative development process was undertaken to identify the attributes of self-management
using 5 steps. First, a literature review was undertaken to identify and understand themes relating to self-management
of DM to inform a topic guide. Second, the topic guide was further refined following consultation with a Patient and
Public Involvement group. Third, the topic guide was used to inform semi-structured interviews with patients with
Type 1 DM (T1DM) and Type 2 DM (T2DM) to identify how self-management of DM affects individuals. Fourth, the
research team considered potential attributes alongside health attributes from an existing measure (Diabetes Health
Profile, DHP) to produce an instrument reflecting both health and self-management outcomes simultaneously. Finally,
a draft instrument was tested in a focus group to determine the wording and acceptability.
Results: Semi-structured interviews were carried out with 32 patients with T1DM and T2DM. Eight potential attributes
were identified: fear/worry/anxiety, guilt, stress, stigma, hassle, control, freedom, and feeling supported. Four
of these self-management attributes were selected with four health attributes (mood, worry about hypos
(hypoglycaemic episodes), vitality and social limitations) to produce the Health and Self-Management in
Diabetes (HASMIDv1) questionnaire.
Conclusions: HASMIDv1 is a short questionnaire that contains eight items each with four response levels to
measure the impact of self-management in diabetes for both T1DM and T2DM. The measure was developed using a
mixed-methods approach that involved semi-structured interviews with people with diabetes. The measure has high
face validity. Ongoing research is being undertaken to assess the validity of this questionnaire for measuring the
impact of self-management interventions in economic evaluation.
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Background
The estimated diabetes mellitus (DM) prevalence world-
wide for 2011 was 366 million people and is expected to
increase to 552 million by 2030 [1]. These prevalence
rates put a considerable financial burden on the health-
care budget of each country. Patient self-management is
crucial for the control of blood glucose, which largely
determines the chances of developing DM complications
over the long-term. Although health care professionals
may provide advice and guidance about medications,
food intake and the effects of physical activity, the main
factors determining success is achieving and maintaining
metabolic control are the ability and willingness of the
patient to self-manage these tasks themselves [2]. Several
large trials on self-management in DM have been con-
ducted [3, 4], and strong evidence exists showing that
self-management is essential to maintain ideal blood glu-
cose levels and to avoid long-term diabetes-related
events [5].
Cost-effectiveness analyses have been undertaken to
examine the impact of self-management on DM in terms
of cost per quality adjusted life year (QALY), where
quality of life is assessed on a scale from zero for states
as bad as being dead to one for full health [6]. These
analyses have typically taken the United Kingdom (UK)
NHS healthcare perspective, where the within-trial
(short-term) and lifetime (long-term) modelling out-
comes had focussed strictly on the improvements in
clinical outcomes and health-related QALYs, such as the
EQ-5D, or used utility estimates obtained for descrip-
tions of the processes of care, such as the insulin regi-
men, rather than the consequences of self-management
on quality of life [7–10]. The use of health related mea-
sures like EQ-5D means the day to day consequences of
self-management for the life’s of patients is being ex-
cluded. The use of specific processes of care limits the
ability to compare across different self-management in-
terventions. Furthermore, self-management differs con-
siderably between the two main types of diabetes, partly
because the therapies are usually very different. In type 1
diabetes mellitus (T1DM) there is an absolute insulin
deficiency so insulin therapy is mandatory from the out-
set, versus type 2 diabetes mellitus (T2DM) where there
is a relative insulin deficiency and a variety of treatments
from diet, to tablets, to injectable therapies, may be
required depending on the duration and stage of the
condition. For either condition, a method is required for
assessing the non-health impact of self-management,
which is not treatment specific and can be used in differ-
ent groups of patients and over time. This paper de-
scribes the development of a patient-report descriptive
system (or questionnaire) that can be used to evaluate
the impact of self-management in diabetes for both
T1DM and T2DM. The project followed an iterative
process, and was informed by patient views throughout,
to ensure good face validity.
Methods
Figure 1 illustrates the process used to develop the
questionnaire.
Step I: Development of a topic guide
A rapid literature review was undertaken to identify and
understand themes related to self-management of both
T1DM and T2DM to inform a topic guide for the
Fig. 1 Development of HASMIDv1 questionnaire
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interviews with individuals with T1DM and T2DM. The
literature search was conducted at the project outset in
May 2014, details of the strategy are shown in Additional
file 1: Appendix 1. We selected for review papers pub-
lished in the last 2 years that reported themes of self-
management, which produced 11 papers. All potential
themes that were reported are shown in Additional file 1:
Appendix 2, and these were used to produce an initial
long list of themes for consideration for the topic guide.
Step II: Topic guide refinement
The potential themes were then considered by the whole
research team. Potential themes across both T1DM and
T2DM were considered jointly as largely the same
themes were raised for both types. Potential themes were
excluded if they were based upon health status, health-
related questions (i.e., depression), or specifics of a
process or intervention (e.g., Insulin regimen, face-to-
face or web-based education). The remaining themes
were categorised into one of four main overarching cat-
egories: task-related, physical, emotional, and social.
Additional themes were added to the topic guide by
the research team. These included information overload,
reinforcement of behaviours, regret or guilt, and coping.
The potential themes were used to generate a draft topic
guide for interviews with patients with diabetes. The
draft topic guide was considered by a Patient and Public
Involvement (PPI) panel. The panel made a number of
suggestions, including the order in which themes could
be introduced in the interview and some additional
themes to include such as peer pressure, blame and self-
image (Additional file 1: Appendix 3). No consensus had
to be achieved for an additional theme to be added to
the topic guide. If any member of the panel felt an add-
itional theme was necessary this was included. The final
lists of themes used in the topic guide are shown in
Table 1.
Step III: Interviews with patients: Methods
Semi-structured interviews were conducted with individ-
uals with T1DM and T2DM. The inclusion criteria were
that the participant had a clinical diagnosis of DM, over
the age of 18 years, and able to provide informed con-
sent. Potential participants who satisfied the inclusion
criteria were identified from Sheffield Teaching Hospi-
tals NHS Foundation Trust, a GP practice (which has
two sites in Sheffield) and the Sheffield Teaching Hospitals
NHS Foundation Trust Research Database for Diabetes,
Endocrinology and Retinal Screening. Prior to the inter-
view, each participant had received an information sheet
detailing the study. Written consent was obtained prior to
the interview being conducted. Following and during the
interview, demographic information was obtained to
ensure that a balanced sample was achieved for both
T1DM and T2DM.
The developed topic guide was used for the interviews
and contained themes to be discussed with the partici-
pants, instead of a set of specific questions. The aim of
the interviews was to identify how self-management of
DM affects individuals. Participants were encouraged to
talk about issues via open-ended questions, and the
individual’s responses were probed to try to identify
what aspects of self-management impacted upon their
daily lives.
Each interview was digitally recorded, allowing the re-
searcher to devote full attention to the interview itself
[11]. The interviews were transcribed verbatim. The tran-
scripts were imported into QSR NVivo 10© (QSR Inter-
national, Doncaster, Australia), a computer-assisted,
Table 1 Themes to be included in topic guide for interviews
with patients with DM
Task-related
Monitoring and burden
Information overloada
Satisfaction
Reinforcement of behavioura
Getting feedback on performance/satisfaction
Self-efficacy
Problem solving
Physical
Exercise
Healthy eating
Being active
Emotional
Stress
Distress
Denial
Acceptance
Regret/guilta
Confidence
Copinga
Control
Empowerment – reduced decision-making
Blamea
Self-imagea
Social
Support
Relationship stress
Peer pressurea
Understanding of others
aadditional themes added by PPI panel
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qualitative data analysis software package, to manage the
data and to facilitate analysis. The analysis was guided by
the research question “What are the ways in which self-
management impacts on QoL?” The aim of the analysis
was to identify how self-management of diabetes impacts
upon the individual. Thematic content analysis (where
themes are identified in which both the content and the
context of the documents are analysed) was undertaken
using Framework [11]. Framework follows the principles
of classifying and organising data according to key themes,
concepts and emergent categories [11]. An initial frame-
work based upon the topic guide was used to guide the
analysis, with an emphasis on how self-management of
DM impacts upon the individual. Specific process-related
attributes of self-management were not included, as this
would potentially limit the findings of this study to specific
self-management interventions. Instead the research aim
was to identify attributes related to how self-managing
DM impacts upon an impact upon an individual, which
could be subject to change following a self-management
intervention (i.e., feeling more in control of their DM).
Each transcript was reviewed several times in order to be-
come familiar with the data. Key phrases, sentences and
words were identified that related to self-management of
diabetes. Any emergent themes were identified. The tran-
scripts were then re-examined and coded according to the
identified themes. Once the transcripts were coded into
themes, the data was organised into potential attributes
that were considered for the questionnaire. Transcripts
for both T1DM and T2DM were considered together.
Interviews with patients: Results
Patient sample characteristics
All interviews were conducted between 3rd October
2014 and 24th November 2014. Thirty-two participants
were interviewed (T1DM n = 16, T2DM n = 16). One of
the interviews was terminated early, as the participant
gave limited one-word answers, despite attempts to en-
courage more explanation behind their responses. Table
2 show a summary of the characteristics of the study
population. The sample covers all the main groups of
age, gender, HbA1c, age at diagnosis and duration of
DM. There was a good spread between T1DM and
T2DM. Interviews varied in length from approximately
12 to 64 min, with an average interview length of
32 min. Recruitment continued until data saturation was
reached, and the number of interviews conducted
exceeded this point. Confidence that data saturation was
achieved was high, as all interviews were conducted by
one researcher (JC).
Potential attributes for the descriptive system
Analysis of the qualitative data identified eight potential
attributes to be considered for the descriptive system.
Fear/Anxiety
Participants discussed emotional responses to having
DM, and/or self-managing the condition. Fears, worries
and anxieties were linked with a number of components
of DM and self-management. Some fears were associated
with DM treatment, particularly with insulin. These in-
cluded a fear of needles, and a fear of being on insulin
and the implications that this would have on the individ-
ual. Participants also discussed fears or worries of not
administering insulin correctly. Such anxieties did not
seem to be associated with the length of time that the
individual had been on a given type of medication. Indi-
viduals still felt uncertain they were doing things as they
should, and had a persistent low level of worry despite
being on the same medication pathway for a prolonged
time period. Some participants spoke of a worry of what
diabetes and the implications of having diabetes would
mean for them in the long-term. This was linked to the
level of information (or lack of) on how DM affects the
body, and so some individuals appeared to have a low
level of understanding, and as such felt anxious that they
would experience problems in the future. Other individ-
uals felt that having too much information was not
helpful in allaying fears or worries.
Guilt
Feelings of guilt were discussed by some of the partici-
pants, particularly in the context of blood sugar levels.
Participants noted that when blood sugar level readings
were high as a result of their behaviour, they often felt
guilt and shame. Some individuals who had T1DM, and
were diagnosed a number of years ago spoke of guilt
associated with particular foods. This was still experi-
enced despite alternative approaches to diabetes self-
management which have since become the norm (e.g.,
feelings of guilt after eating chocolate. Historically indi-
viduals with DM were advised not to eat sweet foods.
Recently self-management plans allow for consumption
of all food types, providing insulin regimes are considered.
Stigma
Participants noted that there is a stigma associated with
DM. One participant related this to when they were dis-
playing symptoms of a hypoglycaemic episode (commonly
referred to as a ‘hypo’). However, most of the comments re-
garding the stigma of diabetes related to diabetes monitor-
ing and treatment. A number of individuals felt that either
monitoring blood sugar levels or administering medication
in a public place was not appropriate due to the negative
connotations associated with needles. Those individuals al-
tered their own behaviour due to how their actions may be
perceived, particularly if children were present.
There was also a feeling that diabetes is negatively por-
trayed by the media, particularly T2DM. Obesity and
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poor diet and the media’s portrayal of these in associ-
ation with diabetes were discussed by some participants.
Some individuals went further to discuss how weight
and weight management issues were raised by clinicians.
They felt there was a misconception that individuals
with diabetes had a poor diet or were overweight due to
poor decision-making.
Control
The term “control” was often used by participants, how-
ever it became apparent that the meaning of control was
different for different people. Some participants referred
to control in the context of controlling their blood sugar
levels, or controlling their diabetes and management of
it. For example, individuals discussed keeping control of
their diabetes in the context of the monitoring of their
blood sugar levels. They would routinely monitor their
levels, and perhaps keep a written record of what those
readings were. In doing so, they experienced feelings of
control, irrespective of what the blood sugar level read-
ings were. Conversely, others spoke of control in that
they were able to keep their blood sugar level readings
within a given range.
Control was also discussed specifically in the context
of self-management. Some individuals felt that they were
in control of their diabetes as they could control what
they chose to eat, how and when to modify daily behav-
iours, such as what to eat, or when to test blood sugar
levels. This could be interpreted that they were more in
control of the self-management of their DM, and does
not necessarily equate to achieving good control of their
blood sugar levels. For some individuals control of be-
haviours (and possibly blood sugar levels) meant they
felt in control of minimising the risk of diabetes-related
complications in the future.
Hassle
Some individuals noted that having diabetes was a ‘has-
sle’. For some this was related to attending appointments
with professionals in order to monitor their DM or
diabetes-related complications. Issues such as taking
time off work, travelling to and from appointments,
parking and so on were problematic (to varying degrees).
Others noted having to monitor blood sugar levels was a
hassle and it was something that had to be fitted in to
daily activities/routine. Although it is not a particularly
time-consuming task for most, it was “something else”
to have to deal with. Participants mentioned that having
to carry blood sugar monitoring equipment, and/or food
and medication was also a hassle.
Stress
The term “stress” was frequently used by participants,
but its meaning varied between participants. Some noted
that there was a degree of stress associated with being
diagnosed with DM. For some individuals the stress was
associated with uncertainty about the future (what the
implications of having diabetes would be for them or
how diabetes self-management would impact upon their
life). Others spoke of stress relating to managing their
diabetes, (planning the day ahead, carrying equipment
round etc.). Some participants acknowledged that even
routine appointments with health care professionals
were a stressful experience. They had concerns over
whether they were managing their blood sugar levels
correctly, achieving stable and consistent blood sugar
levels over a period of time, administering medication
correctly, whether their diabetes was “stable” and/or
whether there had been any implications of having dia-
betes on areas of their health (such as neuropathy). Indi-
viduals noted that there was a degree of stress with the
“review appointments”, and spoke of concerns of being
“told off”.
Feeling supported
Individuals noted that self-managing DM was positively
affected by feeling supported. The type of support re-
ceived (and wanted) varied from one person to another.
To some the support came from friends and family, and
manifested itself in a variety of ways. These included
having someone to go with them to appointments, help-
ing lifestyle changes and choices (such as diet and exer-
cise), being there to talk/listen, reminded about
monitoring blood sugar levels or to take medication.
Some individuals discussed about the need for support
from professionals. The level and meaning of support
did vary between respondents. They included issues such
as getting regular feedback on performance, up-to-date
information on diabetes management, a point of contact
for questions, and maintaining motivation. Some indi-
viduals acknowledged that regular interaction with pro-
fessionals/clinicians was important to avoid becoming
blasé over DM self-management. For some participants
having the knowledge and understanding of diabetes and
how to manage the condition was vital in order for them
to firstly accept the diagnosis, and then to comply with
good diabetes self-management techniques.
Freedom
Participants noted that having DM meant that there was
a lack of freedom in how they chose to live their daily
lives. This could be linked to what activities they chose
to do on any given day, or what they chose to eat and
when they chose to eat it. Either of these components
then contributed to individuals having to consider what
they may need to take (or have with them) to monitor
and manage their blood sugar levels (such as testing kit
or insulin). Some participants noted that due to changes
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in how people are advised to self-manage their diabetes,
they have more freedom, particularly with respect to
food choices.
Step IV: Selecting attributes and wording of the items for
the questionnaire
Attributes reflecting both health related quality of life
(HRQoL) and self-management are included in the ques-
tionnaire in order to provide a holistic measure. The
questionnaire is designed therefore to be used in the
economic evaluation of health care interventions for
both T1DM and T2DM that reflects both HRQoL and
self-management outcomes simultaneously.
Health attributes
To identify health attributes for the questionnaire, earlier
psychometric work conducted with the Diabetes Health
Profile (DHP-1/DHP-18) [12, 13] was used as a starting
point. The previous psychometric analyses resulted in a
health state classification system amenable to valuation
to form a diabetes specific preference-based measure,
the DHP-5D. It is based on items from the DHP-18
(mood and barriers to activity) and DHP-1 (fear of
hypoglycaemic attacks), supplemented by an item from
the SF-6D vitality dimension [12, 13]. The DHP-5D has
five dimensions, psychological distress (2 items of mood
and social limitations), disinhibited eating, fear of
hypoglycaemic attack (four response levels) and vitality
(five response levels).
For this study, the content of the DHP-5D was
reviewed by the research team against the results of the
patient interviews. In order to be able to incorporate
more self-management items it was decided to remove
the disinhibited eating item. It was felt that this item
overlapped with some of the self-management attributes.
The wording of the remaining four items was also
reviewed and minor revisions were made to the wording
of one item to make it compatible with the self-
management items.
Self-management attributes
All self-management attributes identified from the pa-
tient interviews were considered by the research team
for inclusion in the questionnaire to go alongside the
health attributes. The general guiding principle was that
attributes should focus on how self-management affects
the patient rather than any specific process-related
issues.
Fear/anxiety were not included as it was felt they
were too vague and in the interviews they were not spe-
cifically related to self-management. Guilt was not in-
cluded as it is a driver of self-management rather than a
consequence of self-management. Stigma was not in-
cluded as it was felt not to be about self-management
per se. Control was included with the sense that it is
about whether you feel in control of your diabetes (ra-
ther than whether you are actually in control). Hassle
was included as it was clearly identified to be related to
self-management. Although the term hassle was used by
the interviewees it was noted that this term needed test-
ing with a patient focus group to make sure it is under-
standable in this population. Stress was included as it
was clearly related to self-management. Feeling sup-
ported was included but it was noted that there was
weaker support for this attribute from the interviews
and so this should be tested in a patient focus group as
to whether it should be included or not. Freedom was
not included as it was felt to be too closely linked to
hassle and control. Therefore four attributes were in-
cluded (control, hassle, stress and support).
The three attributes from the DHP and energy for the
attributes designed to capture HRQoL, and the four at-
tributes identified from the patient interviews cover self-
management, resulting in the following eight attributes
for inclusion in the questionnaire.
1. Mood
2. Hypoglycaemic attacks
3. Social Limitations
4. Energy
5. Control
6. Hassle
7. Stress
8. Support
Developing levels for the attributes
Levels for each of the self-management and energy attri-
butes were developed by the research team. The number
and wording of levels were informed by the existing se-
verity levels used in the DHP in order to aim for
consistency across the questionnaire. Decisions were
made about whether attributes were about the severity
or frequency of an attribute based on the patient
interviews.
Step V: Testing the draft version of the questionnaire
Focus group
The draft descriptive system was taken to a focus group
which consisted of 4 diabetes patients (a mixture of
T1DM and T2DM) who were asked to comment on the
following:
1. The response options of the items (frequency vs.
severity)
2. Whether feeling supported should be included as
this was the weakest attribute arising from the
qualitative research
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3. Whether the term hassle was suitable and
understandable
4. The overall wording of the questionnaire
Results from the focus group were that the control at-
tribute was clearly identified to be about severity. Pa-
tients commented that the highest level for the control
(severity) question (total control of diabetes) was not
really possible. The levels for control were therefore al-
tered accordingly. There was agreement that the support
dimension should be included, and that the term hassle
was good, clear and understandable. Suggestions were
made that support should include an explanation in
brackets that it is about both clinical and family support.
In response to feedback from the focus group, the de-
scriptive system was subsequently revised.
Administering the draft questionnaire
The revised questionnaire was piloted online with 15
DM patients. Patients were asked to complete the de-
scriptive system and give general feedback on whether it
was clear and understandable. All patients completed all
questions. The spread in responses across the levels in
the attributes was good. The only amendment to the
questionnaire was that it was suggested that the descrip-
tion of support should be slightly amended to ‘family,
friends and health care professionals’. The final ques-
tionnaire (Health and Self-Management in Diabetes
questionnaire, HASMID version 1) is shown in Table 3.
The HASMIDv1 questionnaire consists of 8-items, each
with four response options. Response options are scored
from 0 to 3, with a higher score indicating little or no
impact upon HRQoL. The overall questionnaire is there-
fore scored from 0 to 24, with a high score indicating
good HRQoL, and a low score indicating poor HRQoL.
Discussion
This paper describes the steps undertaken to develop
HASMIDv1, a questionnaire that can be used to deter-
mine the impact of self-management in diabetes for both
T1DM and T2DM. Current measures are limited in
their ability to compare the effectiveness of interventions
on self-management of diabetes. Clinical outcomes
(e.g., HbA1c) are not always appropriate since these
fail to measure the impact of the condition upon an
individual’s quality of life. Clinical outcome data is
often used as an indicator of treatment success or
failure, however such measures fail to take into ac-
count the patient’s perspective, and cannot capture
how a disease (or condition) impacts upon their daily
lives. In contrast patient reported outcome measures
(PROMs) are self-reported by the patient and take
into account the patient’s perspective. Recently there
has been an increasing demand for PROMs both
within routine clinical practice and research. Good
PROMs must demonstrate key properties, such as re-
liability, validity and sensitivity. Current guidance
advocates instrument developers to make PROM in-
struments and related development history available
and accessible publically [14]. However, the literature
on the development of descriptive systems for PROMs is
sparse in comparison to the assessment of the psychomet-
ric properties of the instrument itself. This paper presents
the development of an instrument that includes questions
on the impact of self-management from the patient’s
perspective.
Many legacy PROMs were developed by collating a list
of potential attributes (questions) from existing instru-
ments and expert opinion. In contrast “bottom-up”
methodologies are being increasingly used in the devel-
opment of other PROMs for both generic and
condition-specific instruments [15–17]. It is argued that
by using qualitative data techniques pertinent issues
from the patient’s perspective are identified. This study
adopted a mixed-methods approach to inform the con-
tent of the descriptive system. A conceptual model of
self-management in T1DM and T2DM was derived fol-
lowing the literature review and interviews with patients.
Item generation was based upon the conceptual model,
with inclusion of existing health attributes that have
been tested within the target population (items from the
DHP-5D). An important consideration during the devel-
opment of the questionnaire was to ensure the instru-
ment would be suitable for both T1DM and T2DM
individuals. Treatment-specific items were not consid-
ered as this could limit the use of the instrument in
evaluating self-management interventions across patient
groups. Further refinement of the instrument was
achieved through cognitive debriefing, incorporating pa-
tients’ views within each aspect of the development
phase, ensuring good content and face validity. The
rigorous and transparent approaches undertaken to de-
velop the HASMIDv1 questionnaire emphasises its use-
fulness as a PROM.
The study is not without its limitations. The qualita-
tive phase included a sample that covered the main age
groups, type of diabetes, and duration of diabetes. How-
ever, the sample was not balanced with respect to ethni-
city. Out of the 32 participants interviewed, only 4
participants were non-white. Due to time and resource
limitations it was not possible to explore whether any
cultural differences exist with respect to self-
management of diabetes. Further work is needed to
determine whether there are any additional items that
may be relevant in a more diverse population. The
items assessing health were taken from an existing
measure (DHP) and were generated separately to the
self-management items.
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Further work is ongoing to formally assess the psycho-
metric properties of the HASMIDv1 measure using a
large patient sample.
Conclusion
This paper has described the development of a ques-
tionnaire for self-management and health outcomes
in diabetes for both T1DM and T2DM. The HAS-
MIDv1 questionnaire is a short, easy-to-complete
PROM. It has been developed following a series of
rigorous iterations, with high involvement of patients
and service-users to ensure good face validity. Fur-
ther work is currently being undertaken to assess the
performance of the HASMIDv1 questionnaire in an
independent sample, and to examine aspects of reli-
ability, such as the responsiveness (sensitivity to
change) of the instrument.
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Table 3 Descriptive system of the HASMIDv1 questionnaire
Mood You never find yourself losing your
temper over small things
You sometimes find yourself losing
your temper over small things
You usually find yourself losing
your temper over small things
You always find yourself losing
your temper over small things
Hypoglycaemic attacks You never worry about going
hypo
You sometimes worry about going
hypo
You usually worry about going
hypo
You always worry about going
hypo
Energy You are never tired
You are sometimes tired
You are usually tired
You are always tired
Social Limitations Your days are never tied to
mealtimes
Your days are sometimes tied to
meal times
Your days are usually tied to meal
times
Your days are always tied to meal
times
Control You feel you have a lot of control
of your diabetes
You feel you have some control of
your diabetes
You feel you have little control of
your diabetes
You feel you have no control of
your diabetes
Hassle You find your life with diabetes is
never a hassle
You find your life with diabetes is
sometimes a hassle
You find your life with diabetes is
often a hassle
You find your life with diabetes is
always a hassle
Stress You find your life with diabetes is
never stressful
You find your life with diabetes is
sometimes stressful
You find your life with diabetes is
often stressful
You find your life with diabetes is
always stressful
You feel totally supported with
your diabetes
Table 3 Descriptive system of the HASMIDv1 questionnaire
(Continued)
Support (All support you have;
from family, friends and health care
professionals)
You feel you have a lot of support
with your diabetes
You feel you have a little support
with your diabetes
You feel you have no support with
your diabetes
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